Dendreon Corp (DNDN)

Dendreon is a biotech company working to create therapies that harness our own immune system to fight cancer. The company's name is a play on the word dendrite, which is a anatomical term used to describe brain cells. It sort of makes sense.

Show Chart

Events

  • June 42012
    Dendreon Corp. Presents at Jefferies 2012 Global Healthcare Conference, Jun-04-2012 04:30 PM
  • June132012
    Dendreon Corp., Annual General Meeting, Jun 13, 2012
  • August 62012
    Dendreon Corp. expected to report Q2 2012 results on August 6, 2012. This event was calculated by Capital IQ (Created on May 9, 2012).
  • February272013
    Dendreon Corp. expected to report Fiscal Year 2012 results on February 27, 2013. This event was calculated by Capital IQ (Created on May 10, 2012).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $-0.54 (-7.00%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed